Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Miura

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Anticancer Research|March 8, 2019
Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1Norimitsu Kasahara, Noriaki Sunaga, Yusuke Tsukagoshi, et al.
Chemotherapy|July 17, 2020
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung CancerMie Kotake, Tomohito Kuwako, Hisao Imai, et al.
Thoracic Cancer|November 28, 2023
The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancerNoriaki Sunaga, Kyoichi Kaira, Kimihiro Shimizu, et al.
The American Journal of Case Reports|December 10, 2024
Rare Case of Fusobacterium necrophorum Bacteremia and Pleural Empyema Originating from a Burn Ulcer in a 16-Year-Old Female PatientMasakiyo Yatomi, Chihiro Hashimoto, Shunichi Kouno, et al.
Thoracic Cancer|February 28, 2024
Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrenceYoichi Ohtaki, Toshiteru Nagashima, Naoko Okano, et al.
Anticancer Research|May 17, 2019
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung CancerKyoichi Kaira, Hisao Imai, Ryousuke Souma, et al.
Anti-Cancer Drugs|February 2, 2023
Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case reportNoriaki Sunaga, Yosuke Miura, Reiko Sakurai, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2013
Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancerKyoichi Kaira, Yoshio Tomizawa, Reiko Yoshino, et al.
Thoracic Cancer|December 28, 2024
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab TherapyNao Kobayashi, Noriaki Sunaga, Masakiyo Yatomi, et al.
Radiology Case Reports|August 23, 2021
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumoniaIkuo Wakamatsu, Masakiyo Yatomi, Shogo Uno, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Anticancer Research|March 8, 2019
Post-treatment Glasgow Prognostic Score Predicts Efficacy in Advanced Non-small-cell Lung Cancer Treated With Anti-PD1Norimitsu Kasahara, Noriaki Sunaga, Yusuke Tsukagoshi, et al.
Chemotherapy|July 17, 2020
Phase II Study of Weekly Nanoparticle Albumin-Bound Paclitaxel as Second- or Third-Line Therapy in Patients with Advanced Non-Small Cell Lung CancerMie Kotake, Tomohito Kuwako, Hisao Imai, et al.
Thoracic Cancer|November 28, 2023
The oncogenic role of LGR6 overexpression induced by aberrant Wnt/β-catenin signaling in lung cancerNoriaki Sunaga, Kyoichi Kaira, Kimihiro Shimizu, et al.
The American Journal of Case Reports|December 10, 2024
Rare Case of Fusobacterium necrophorum Bacteremia and Pleural Empyema Originating from a Burn Ulcer in a 16-Year-Old Female PatientMasakiyo Yatomi, Chihiro Hashimoto, Shunichi Kouno, et al.
Thoracic Cancer|February 28, 2024
Prognosis of non-small cell lung cancer with postoperative regional lymph node recurrenceYoichi Ohtaki, Toshiteru Nagashima, Naoko Okano, et al.
Anticancer Research|May 17, 2019
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung CancerKyoichi Kaira, Hisao Imai, Ryousuke Souma, et al.
Anti-Cancer Drugs|February 2, 2023
Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case reportNoriaki Sunaga, Yosuke Miura, Reiko Sakurai, et al.
Lung Cancer (Amsterdam, Netherlands)|August 10, 2013
Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancerKyoichi Kaira, Yoshio Tomizawa, Reiko Yoshino, et al.
Thoracic Cancer|December 28, 2024
A Case of Primary Lung Adenocarcinoma With Recurrent Brain Metastasis due to Transformation to Small Cell Carcinoma During Adjuvant Atezolizumab TherapyNao Kobayashi, Noriaki Sunaga, Masakiyo Yatomi, et al.
Radiology Case Reports|August 23, 2021
A case of a patient with neurofibromatosis type I who developed pneumothorax and eosinophilic pleural effusion after suffering from COVID-19 pneumoniaIkuo Wakamatsu, Masakiyo Yatomi, Shogo Uno, et al.
Pageof 5